↓ Skip to main content

Phase III, randomized, open-label study of durvalumab (MEDI4736) in combination with tremelimumab or durvalumab alone versus platinum-based chemotherapy in first-line treatment of patients with…

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
23 Mendeley